Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eagle Pharmaceuticals Inc (EGRX)
NASDAQ:EGRX
Eagle Pharmaceuticals (EGRX) Ownership - Who Owns Eagle Pharmaceuticals?
171 Followers
Eagle Pharmaceuticals (EGRX) Ownership Overview
The ownership structure of Eagle Pharmaceuticals (EGRX) stock is a mix of institutional, retail and individual investors. Approximately 61.12% of the company’s stock is owned by Institutional Investors, 14.77% is owned by Insiders and 24.11% is owned by Public Companies and Individual Investors.
14.77% Insiders
24.22% Mutual Funds
36.90% Other Institutional Investors
24.11% Public Companies and
Individual Investors
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 31, 2023 | Michael Graves. Director | Bought | $46238 |
| May 18, 2023 | Scott Tarriff Ceo,director, >10% Owner | Sold | $299700 |
| May 15, 2023 | Scott Tarriff Ceo,director, >10% Owner | Sold | $930656 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | Sold | $797141 | |
| Sep 30, 2023 | Bought | $17888904 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,538,070.00 | Insider | 11.84% | 9,136,135.80 | |
| 1,134,363.00 | Institution | 8.73% | 6,738,116.22 | |
| 1,072,772.00 | Institution | 8.26% | 6,372,265.68 | |
| 618,251.00 | Institution | 4.76% | 3,672,410.94 | |
| 487,684.00 | Institution | 3.76% | 2,896,842.96 | |
| 430,619.00 | Institution | 3.32% | 2,557,876.86 | |
| 215,288.00 | Institution | 1.66% | 1,278,810.72 | |
| 105,504.00 | Institution | 0.81% | 626,693.76 | |
| 104,505.00 | Institution | 0.80% | 620,759.70 | |
| 102,377.00 | Institution | 0.79% | 608,119.38 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,072,772.00 | Institution | 8.26% | 6,372,265.68 | |
| 487,684.00 | Institution | 3.76% | 2,896,842.96 | |
| 215,288.00 | Institution | 1.66% | 1,278,810.72 | |
| 104,505.00 | Institution | 0.80% | 620,759.70 | |
| 102,377.00 | Institution | 0.79% | 608,119.38 | |
| 89,733.00 | Institution | 0.69% | 533,014.02 | |
| 74,033.00 | Institution | 0.57% | 439,756.02 | |
| 72,289.00 | Institution | 0.56% | 429,396.66 | |
| 70,934.00 | Institution | 0.55% | 421,347.96 | |
| 69,803.00 | Institution | 0.54% | 414,629.82 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 336,766.00 | Institution | 2.59% | 4,623,797.00 | |
| 150,918.00 | Institution | 1.16% | 2,072,104.00 | |
| 245,693.00 | Institution | 1.89% | 1,459,416.42 | |
| 102,144.00 | Institution | 0.79% | 606,735.36 | |
| 40,620.00 | Institution | 0.31% | 557,713.00 | |
| 93,008.00 | Institution | 0.72% | 557,117.92 | |
| 30,914.00 | Institution | 0.24% | 424,449.00 | |
| 19,797.00 | Institution | 0.15% | 373,767.36 | |
| 15,534.00 | Institution | 0.12% | 331,201.04 | |
| 48,314.00 | Institution | 0.37% | 289,400.86 |
FAQ
Who Owns Eagle Pharmaceuticals Inc (EGRX)?
According to the latest TipRanks data, approximately 36.90% of the company's stock is held by institutional investors, 14.77% is held by insiders, and 24.11% is held by retail investors.
What percentage of Eagle Pharmaceuticals Inc (EGRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.90% of Eagle Pharmaceuticals Inc (EGRX) stock is held by institutional investors.
What percentage of Eagle Pharmaceuticals Inc (EGRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 24.11% of Eagle Pharmaceuticals Inc (EGRX) stock is held by retail investors.
Who owns the most shares of Eagle Pharmaceuticals Inc (EGRX)?
Scott Tarriff owns the most shares of Eagle Pharmaceuticals Inc (EGRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.